Vagal activity reduces inflammatory response in patients with STEMI treated with primary PCI and GPIIbIIIa inhibitors

被引：0
|
作者：
Somaschini, A. [1 ,2 ]
Demarchi, A. [1 ,2 ]
Cornara, S. [1 ,2 ]
Ferlini, M. [3 ]
Crimi, G. [3 ]
Ravera, A. [1 ,2 ]
Mandurino-Mirizzi, A. [1 ,2 ]
Camporotondo, R. [4 ]
Visconti, L. Oltrona [3 ]
De Ferrari, G. M. [1 ,2 ]
De Servi, S. [2 ,5 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, Coronary Care Unit, Pavia, Italy
[2] Univ Pavia, Dept Mol Med, Pavia, Italy
[3] Fdn IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, Coronary Care Unit, Pavia, Italy
[5] IRCCS Mutimed, Sesto San Giovanni, MI, Italy
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1756
引用
收藏
页码：389 / 389
页数：1
相关论文
共 50 条
  • [11] Gut barrier dysfunction, endotoxemia and inflammatory fl ammatory response in STEMI patients and effect of primary PCI
    Oikonomou, Ioanna
    Papageorgiou, Angeliki
    de Lastic, Anne-Lise
    Moulias, Athanasios
    Georgopoulou, Georgia-Andriana
    Mouzaki, Athanasia
    Koufou, Eleni-Evangelia
    Tsigkas, Grigorios
    Gogos, Charalambos
    Davlouros, Periklis
    Assimakopoulos, Stelios F.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (05): : 485 - 493
  • [12] Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution
    Somaschini, Alberto
    Cornara, Stefano
    Ferlini, Marco
    Crimi, Gabriele
    Camporotondo, Rita
    Gnecchi, Massimiliano
    Ferrario Ormezzano, Maurizio
    Oltrona Visconti, Luigi
    De Ferrari, Gaetano M.
    De Servi, Stefano
    PLATELETS, 2020, 31 (01) : 48 - 54
  • [13] Update on primary PCI for patients with STEMI
    Thomas, Michael P.
    Bates, Eric R.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (02) : 95 - 102
  • [14] Prehospital diagnosis in STEMI patients treated by primary PCI: the key to rapid reperfusion
    R. P. Vermeulen
    T. Jaarsma
    F. G. A. Hanenburg
    J. W. Nannenberg
    G. A. J. Jessurun
    F. Zijlstra
    Netherlands Heart Journal, 2008, 16 : 5 - 9
  • [15] Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
    Domokos, Dominika
    Szabo, Andras
    Banhegyi, Gyongyver
    Major, Laszlo
    Kiss, Robert Gabor
    Becker, David
    Edes, Istvan Ferenc
    Ruzsa, Zoltan
    Merkely, Bela
    Hizoh, Istvan
    PLOS ONE, 2021, 16 (01):
  • [16] Prehospital diagnosis in STEMI patients treated by primary PCI: the key to rapid reperfusion
    Vermeulen, R. P.
    Jaarsma, T.
    Hanenburg, F. G. A.
    Nannenberg, J. W.
    Jessurun, G. A. J.
    Zijlstra, F.
    NETHERLANDS HEART JOURNAL, 2008, 16 (01) : 5 - 9
  • [17] Prognostic role of non-ST resolution and glycoprotein IIbIIIa inhibitors use in STEMI patients treated with primary PCI
    Somaschini, A.
    Cornara, S.
    Ferlini, M.
    Crimi, G.
    Baldo, A.
    Camporotondo, R.
    Ferrario, M. Ormezzano
    Visconti, L. Oltrona
    De Ferrari, G. M.
    De Servi, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 803 - 803
  • [18] Outcome and Inflammatory Response in Aborted Myocardial Infarction Treated with Primary PCI
    Pyda, Malgorzata
    Lanocha, Magdalena
    Kaorybalska, Katarzyna
    Oleskowska-Florek, Weronika
    Filip, Magdalena
    Katarzynska-Szymanska, Agnieszka
    Grajek, Stefan
    CIRCULATION, 2010, 122 (02) : E159 - E159
  • [19] Prognostic value of oral glucose tolerance testing in patients with a primary PCI treated STEMI
    Knudsen, E. C.
    Seljeflot, I.
    Abdelnoor, M.
    Eritsland, J.
    Mangschau, A.
    Arnesen, H.
    Andersen, G. O.
    EUROPEAN HEART JOURNAL, 2010, 31 : 526 - 526
  • [20] Matrix metalloproteinase-2 and oxidative stress in patients with STEMI treated by primary PCI
    Parenica, J.
    Goldbergova-Pavkova, M.
    Kala, P.
    Poloczek, M.
    Manousek, J.
    Cermakova, Z.
    Toman, O.
    Tomandl, J.
    Tomcikova, D.
    Spinar, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 476 - 476
12345